TY - JOUR
T1 - Adverse psychiatric effects associated with herbal weight-loss products
AU - Bersani, Francesco Saverio
AU - Coviello, Marialuce
AU - Imperatori, Claudio
AU - Francesconi, Marta
AU - Valeriani, Giuseppe
AU - De Stefano, Gianfranco
AU - Bolzan Mariotti Posocco, Flaminia
AU - Santacroce, Rita
AU - Minichino, Amedeo
AU - Corazza, Ornella
N1 - Date of Acceptance: 02/08/2015.
Copyright © 2015 F. Saverio Bersani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
PY - 2015
Y1 - 2015
N2 - Obesity and overeating are among the most prevalent health concerns worldwide and individuals are increasingly using performance and image-enhancing drugs (PIEDs) as an easy and fast way to control their weight. Among these, herbal weight-loss products (HWLPs) often attract users due to their health claims, assumed safety, easy availability, affordable price, extensive marketing, and the perceived lack of need for professional oversight. Reports suggest that certain HWLPs may lead to onset or exacerbation of psychiatric disturbances. Here we review the available evidence on psychiatric adverse effects of HWLPs due to their intrinsic toxicity and potential for interaction with psychiatric medications
AB - Obesity and overeating are among the most prevalent health concerns worldwide and individuals are increasingly using performance and image-enhancing drugs (PIEDs) as an easy and fast way to control their weight. Among these, herbal weight-loss products (HWLPs) often attract users due to their health claims, assumed safety, easy availability, affordable price, extensive marketing, and the perceived lack of need for professional oversight. Reports suggest that certain HWLPs may lead to onset or exacerbation of psychiatric disturbances. Here we review the available evidence on psychiatric adverse effects of HWLPs due to their intrinsic toxicity and potential for interaction with psychiatric medications
U2 - 10.1155/2015/120679
DO - 10.1155/2015/120679
M3 - Article
SN - 2314-6133
VL - 2015
JO - BioMed Research International
JF - BioMed Research International
M1 - 120679
ER -